Testosterone
Key facts
| Active substance |
Testosterone
|
| Therapeutic area |
Endocrinology, -gynacology-fertility-metabolism
|
| Decision number |
P/161/2009
|
| PIP number |
Testosterone
|
| Pharmaceutical form(s) |
Transdermal patch
|
| Condition(s) / indication(s) |
Hypoactive sexual desire disorder
|
| Route(s) of administration |
Transdermal use
|
| Contact for public enquiries |
Procter & Gamble Pharmaceuticals UK Ltd
|
| Decision type |
W: decision granting a waiver in all age groups for all conditions or indications
|